A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project
about
sameAs
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney CancerALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literatureHigh-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adultsPhase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersA 61-year-old man with dyspepsia and weight lossPET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular LymphomasPrimary Non-Hodgkin's Lymphoma of the Vulva: A Case Report and Literature ReviewPredictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive LymphomaMolecular Imaging of Biomarkers in Breast CancerPosttransplant lymphoproliferative disorders following liver transplantation: Where are we now?Romidepsin for the Treatment of Peripheral T-Cell LymphomaNext-generation prognostic assessment for diffuse large B-cell lymphomaThyroid lymphoma: recent advances in diagnosis and optimal management strategiesCombating the epigenome: epigenetic drugs against non-Hodgkin's lymphomaConsolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspectiveExtramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challengeTargeting CD19 in B-cell lymphoma: emerging role of SAR3419Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETAssessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working PartyDanish National Lymphoma RegistryNext-generation surveillance strategies for patients with lymphomaMicroarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: identification of genes related to disease progressionThe Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service researchDiffuse large B-cell lymphoma: current strategies and future directionsCHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphomaGenes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphomaMHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersDevelopment and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCLThe project data sphere initiative: accelerating cancer research by sharing dataPatients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapyA strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphomaDiffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.Pretransplant FDG-PET in aggressive non-Hodgkin lymphoma: systematic review and meta-analysis.Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.Bilateral Lymphoblastic Lymphoma of Breast Mimicking Inflammatory Breast Cancer: A Case Report and Review of LiteratureIdentification of predictive pathways for non-hodgkin lymphoma prognosis
P2860
Q21090542-58320CEE-94CE-4273-8192-8F9D02125AF2Q21198873-1E39469E-9A47-4743-BA62-95C5F0407FCDQ24242089-DF284AB0-EBF0-40C3-B581-310E966E3F9BQ24646379-619F320C-C6D0-47E6-A0F1-FB24F5A2053EQ24813742-454BD507-7302-4137-BEDB-8F57499DDCB0Q26752284-0F93C38E-9199-4A6C-842B-32E894F862C7Q26766569-3F00B185-CCAF-4B3C-BD94-BB0136CFB36BQ26771059-78580803-C75A-498C-BEDC-4EE02AD05C8CQ26772870-1DA8C24B-A150-4000-9163-28773352B39AQ26780262-4427874C-03F0-44F7-9BB3-1D0B86A28C52Q26785732-D53DFE02-C2AE-438C-9C8B-3A7D31477D40Q26796428-0411A222-BAF6-418B-B6CE-9B90FC252E1FQ26827420-3F398A0A-4A38-450E-8825-025F92C554C8Q26851166-CC9C93A9-3861-46EE-8E56-0ED6D22B3483Q26998446-45F2DBC4-79AA-4A05-BA45-DC911EF663BEQ27005996-BBA80C2B-81F6-4062-BFDE-7B64D4FAD4BDQ27027562-ECA3603C-4AA5-4CF1-9C3C-29226C53B718Q27314782-A0DEAE9B-4A51-424E-9158-70E755BE341BQ27314809-D8DF924A-93F6-49FC-85AA-2857D5180F34Q27694674-27907539-65C4-417B-8018-206B0444BD78Q28073223-4CDD04FC-81F4-4458-9DA7-BCFF6C899296Q28077997-B6F96A56-CDC3-4DCD-88F4-2EAF24D4A5AEQ28084956-117CEA6F-C9D4-49AC-8957-18653EDF2C55Q28201324-176372EB-E304-41B5-9E62-0B3D1D9036E7Q28266484-C0FF3975-7ECD-47BC-B22E-6C797EF20523Q28269136-084DD5FF-C332-492F-9C3A-299B08A6661BQ28270920-CE7C38DD-2AAC-461B-8A73-57BD4C3319E9Q28276837-03E42A92-043E-4C42-B09A-307065661F95Q28306431-B0925B64-9CDE-4E06-B910-1C88D09BC05CQ28543490-F6BA30FF-0069-48AA-96CA-99A02D388B9AQ28647805-0F4122A0-4D2B-4D12-AC8E-7FE265D17305Q28651110-DBD21106-6A03-41AA-8E2A-F34BD436DA81Q28741787-BEAFEB77-E5E5-4528-9199-91D3FDFD58B3Q30235296-F2B5B5B9-A56E-41AA-A189-499B95775640Q30240084-7043A112-9776-4DD2-BE55-0F8A3C75AD1FQ30240133-A0AE617B-5159-4990-B871-E858EF175165Q30244110-AC1DFC45-DF2E-492B-B771-960F86252988Q30275251-3F6732F9-6759-436A-9938-D7405D1A96C5Q30406231-E5724619-4403-4A6B-B74A-A31D21999FC9Q30497902-84334C2F-A7C0-4811-B870-F29075ADAA1E
P2860
A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project
description
1993 nî lūn-bûn
@nan
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
A predictive model for aggress ...... oma Prognostic Factors Project
@ast
A predictive model for aggress ...... oma Prognostic Factors Project
@en
A predictive model for aggress ...... oma Prognostic Factors Project
@nl
type
label
A predictive model for aggress ...... oma Prognostic Factors Project
@ast
A predictive model for aggress ...... oma Prognostic Factors Project
@en
A predictive model for aggress ...... oma Prognostic Factors Project
@nl
altLabel
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
@en
prefLabel
A predictive model for aggress ...... oma Prognostic Factors Project
@ast
A predictive model for aggress ...... oma Prognostic Factors Project
@en
A predictive model for aggress ...... oma Prognostic Factors Project
@nl
P1476
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
@en
A predictive model for aggress ...... oma Prognostic Factors Project
@en
P356
10.1056/NEJM199309303291402
P407
P577
1993-09-30T00:00:00Z